PRE 103
Latest Information Update: 24 Apr 2007
At a glance
- Originator Prescient NeuroPharma
- Class
- Mechanism of Action Glutamate agonists; Metabotropic glutamate receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Stroke
Most Recent Events
- 17 Oct 2001 Preclinical development for Stroke in Canada (Unknown route)